Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2026-09-15 17:02:46 ET · period of report 2026-09-11 · accession 0001643653-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 17:02 | 2026-09-11 | NBIX | BENEVICH ERIC | Chief Commercial Off | A - Grant | $0.00 | +6,275 | 70.7K | +10% | $0 | |
| 2026-09-15 17:02 | 2026-09-11 | NBIX | BENEVICH ERIC | Chief Commercial Off | F - Tax | $156.22 | -3,386 | 67.3K | -5% | -$529.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | A | A | 6,275 | $0.00 | 70,683 | D | — | — | (F1) The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026. |
| 2 | Common | Common Stock | 2026-09-11 | F | D | 3,386 | $156.22 | 67,297 | D | — | — | (F2) Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold. |